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The capacity of individual animals to mount specific immune responses to 
many antigens is under precise genetic control. One group of genes controlling 
responsiveness  to  individual  antigens  are  the  histocompatibility-linked im- 
mune response (Ir) 1 genes (1). As implied by their name, these genes are linked 
to the major histocompatibility complex (MHC) of the species. Considerable 
experimental  evidence indicates  that IR gene products play a role in antigen 
recognition  by  thymus-derived  (T)  lymphocytes (2). We  have  previously 
demonstrated (3)  that alloantisera prepared  by reciprocal  immunization of 
strain 2 and strain 13 guinea pigs specifically block the activation of T lympho- 
cytes from immune guinea pigs by antigens, the response to which is controlled 
by Ir genes. Thus, when the lymphocytes from (2  X  13)F~ guinea pigs were 
cultured in vitro, anti-2  serum  inhibited the response to a 2,4-dinitrophenyl 
derivative of the  copolymer  of L-glutamic  acid  and L-lysine (DNP-GL,  an 
antigen, the response  to which  is  controllled  by a  2-1inked Ir  gene),  while 
anti-13  serum  inhibited the response  to a  copolymer of L-glutamic acid  and 
L-tyrosine (GT, an antigen, the response to which is controlled by a  13-1inked 
Ir gene). 
A  number of possible  mechanisms  were  suggested  by which  alloantisera 
might block T-lymphocyte antigen recognition.  First, the Ir genes might be 
identical  with  the  genes  controlling  strain  2  or  13  histocompatibility (H) 
specificities. It was felt that this explanation  was unlikely  because studies  in 
the mouse  (4)  have demonstrated that Ir genes are  separate from D  and K 
region genes, which control  the major serologically identifiable H  antigens in 
this species. Second,  the Ir  gene product could  be  physically related  to H 
antigen on the cell surface and allo-antisera might exert their inhibitory func- 
tion by reacting with H antigen and sterically interfering with the function of 
1 Abbreviations used in this paper:  CFA, complete Freund's adjuvant; GL, a copolymer of 
L-glutamic acid and L-lysine; GT, a copolymer of L-glutamic acid and L-tyrosine; H, histo- 
compatibility; Ir, immune response; MHC,  major histocompatibility  complex; PEC, peri- 
toneal  exudate  cells; PELs,  peritoneal  exudate  lymphocytes;  PHA,  phytohemagglufinin; 
PPD, purified protein derivative of tuberculin. 
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the Ir gene product. Thirdly, in addition to anti-H antibodies, the aIloantisera 
may contain antibodies directly reactive with and capable of directly blocking 
the specific Ir gene products. Such antibodies would facilitate the isolation and 
characterization of the Ir gene product and increase our understanding of the 
function of Ir genes in T-lymphocyte antigen recognition. 
In these papers, we will present further studies on the mechanism and spe- 
cificity of alloantiserum-induced inhibition of T-lymphocyte/unction. In the 
first paper,  we will examine the effects of absorption of the alloantisera with 
different populations of  immunocompetent cells  and  attempt  to  determine 
whether the inhibitory  antibody is directed against antigens solely on T lympho- 
cytes, or, alternatively, against antigens also present on bone marrow-derived 
(B)  lymphocytes. We will also compare  the effects of the alloantisera with a 
number of  anti-immunoglobulin reagents  on  the  inhibition of  the  in  vitro 
lymphocyte proliferative response to  antigen. 
Materials and Methods 
Animals.--Inbred strain 2 and strain 13 guinea pigs were obtained from the Division of 
Research Services, National Institutes of Health,  Bethesda, Md.  (2 X  13)F1 animals were 
obtained by mating strain 2 with strain 13 animals in our own colony. 
Antigens.--A copolymer of r.-glutamic  acid (60%) and L-lysine (40%) (GL) with an average 
mol wt of 115,000 was obtained from the Pilot Chemical Division of New England Nuclear 
Corp., Boston, Mass.  DNPa-GL was prepared by the reaction of  2,4-dinitrofluorobenzene 
with GL (5). The subscript refers to the average number of DNP groups/molecule. A co- 
polymer of L-glutamic acid (500/0) and L-tyrosine (50%) (GT), mol wt 22,600, was obtained 
from Miles Laboratories, Inc., Miles Research Div., Kankakee, Ill. Purified protein derivative 
of tuberculin (PPD) was purchased from Connaught Medical Research Laboratories, Ontario, 
Canada.  Phytohemagglutinin  (PHA) was obtained from Wdlcome  Research Laboratories, 
Beckenham, England. 
Immunization  of Guinea Pigs.--Solutions of each antigen in 0.15 M phosphate buffer, pH 
7.4 containing 0.15 M  NaC1 were emulsified with an equal volume of complete Freund's 
adjuvant (CFA) containing 0.5 mg of Mycobacterium butyricum/ml (Difco Laboratories, 
Detroit,  Mich.). F1 animals were immunized simultaneously with 100/zg of DNP-GL and 
500 #g of GT; each antigen was administered in one front footpad and one rear footpad. 
Preparation of Alloantisera.--A  strain 13 antistrain 2 serum and a strain 2 antistrain 13 
serum were prepared by cross-immunizing  strain 2 and strain 13 animals with a CFA emulsion 
of a homogenate of lymph node and spleen cells. The animals were boosted 2 and 4 wk after 
primary immunization  by an intradermal  injection of a homogenate of lymph node and spleen 
cells. The sera used in these studies were obtained 8-10 wk after initial immunization. They 
were sterilized by Millipore filtration and heat inactivated at 56°C for 45 rain before use. 
L2C Leukemia Cdls.--The L2C leukemia cells were originally a gift of Dr. L. Kaplow, Yale 
University, and have been maintained by serial passage in strain 2 animals in our colony. 
Leukemia cells were obtained from the peripheral blood of moribund animals with peripheral 
white blood cell counts in excess of 200,000/mm  3 by gelatin sedimentation as previously de- 
scribed (6). 
Cytotoxiclty Testing.--The 13 anti-2 serum was tested in a 51Cr release assay as previously 
described (7). In brief, 50 X  10  s lymph node cells or L2C leukemia cells were incubated in 1 
ml of Hanks' balanced salt solution containing 10% heat-inactivated  fetal calf serum  (In- 
dustrial Biological Laboratories, Rockville, Md.)  and 100 #Ci  51Cr (spec act  185 #Ci/#g, 
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times and resuspended in media at a concentration of 10 X  10  ~/ml. An aliquot (0.1 mi) of 
this suspension was then added to 10 x 75-mm glass tubes, followed by 0.1  ml of the appro- 
priate dilution of antibody and 0.1 mi of a 1:2 dlilution of lyophilized guinea pig serum (Grand 
Island Biological Co., Grand Island, N. Y.) as a source of complement (C).  Mter a 30  min 
incubation at 37°C, the cells were sedimented by centrifugation at 1,500 rpm and the radio- 
activity in 0.1 ml of the supernate was measured. The amount of radioactivity in the sample 
was compared with the radioactivity present in an equal volume from tubes which contained 
cells in medium plus C only and with that present in tubes which were frozen and thawed four 
times. The percent maximum ~lCr release was calculated as follows: 
radioactivity released by antiserum dilution 
--  radioactivity released in absence of antiserum 
%  51Cr release =  X  100. 
radioactivity released by frozen thawed cells 
--  radioactivity released in absence of antiserum 
Absorption of  AUoantisera.--In the majority of studies I X 109 cells were used to absorb the 
equivalent of i ml of undiluted antiserum; the sera were absorbed with an equal volume of the 
absorbing cell suspension for 2 h at 4°C. The absorbed antiserum was then spun at 15,000 rpm 
for 30 rain and sterilized by Mlllipore filtration. 
Anti-Immuuoglobulin  Reagenls.--A  number  of different antiguinea  pig immunoglobulin 
reagents were used. Rabbits were immunized with either 2 mg of guinea pig gamma globulin 
(Fraction II, Miles Laboratories)  or 2 mg of a  Fab fragment of guinea pig 3"3 globulin  (a 
generous gift of Dr. V. Nussenzweig, New York University School of Medicine). Two separate 
lots of the anti-Fab serum were prepared. The antiguinea pig Ig reagent was reactive with 3"1, 
3'2, and 3"M heavy chains and with Fab fragment as determined by Ouchterlony analysis;  the 
two anti-Fab reagents were reactive only with the Fab fragments. A rabbit antiserum specific 
for 3"2 heavy chains was  a  gift of Dr.  J.  Davie of the Washington  University School of 
Medicine; the method of antibody purification and the specificity of this antibody have been 
previously described (8). All of the anti-immunoglobulin reagents had at least 1-2 nag of an- 
tibody protein/ml of serum.  Before use in cell cultures,  the anti-immunoglobulin reagents 
were  fractionated  by  ammonium  sulfate precipitation and  dialyzed against culture media. 
Cell Collection and Puri.fication.--The  techniques for the collection of peritoneal exudate 
cells  (PEC)  have been described previously (9).  In brief, animals were injected intraperi- 
toneally with 25 ml of sterile mineral oil (Marcol 52, Humble Oil & Refining Co., Houston, 
Texas). 3--4 days later the exudate cells were harvested by lavaging the peritoneal cavity with 
150 ml of Hanks' balanced salt solution. The resultant PEC population is composed of about 
75% macrophages, 10% neutrophils, and 15% lymphocytes. Peritoneal exudate lymphocytes, 
a population of highly enriched antigen-reactive T lymphocytes were obtained by passing the 
PEC  over adherence  columns.  After purification  the  resultant population  is composed of 
80-90% lymphocytes and  10-20% macrophages. 
Technique of Brief Antigen Exposure.--In  all of the experiments described in this report, 
the unfractionated PEC population was used as the source of macrophages. PEC at a concen- 
tration of 15 X  10  e/ml in the presence of 30 Izg/ml of mitomycin C (Nutritional Biochemicals, 
Cleveland, Ohio) were allowed to equilibrate at 37°C for 60 min. Mitomycin C was employed 
in order to inhibit DNA synthesis by the small number of lymphocytes present in the PEC 
population. The final concentration of antigen or mitogen used in the incubation medium was 
100/zg/ml DNP-GL, 100/zg/ml GT, 100/zg/ml PPD, or 10/~g/ml PHA. At the end of the 
exposure period the cell suspensions  were washed four times with media. 
In Vitro Assay of Antigen-Induced DNA Synthesis.--Antigen-pulsed  PEC at a concentra- 
tion of 1 X  106/ml were mixed with exudate lymphocytes at a concentration of 2 X  106/ml. 
0.2  ml aliquots of these mixtures were cultured in round-bottom  microfiter plates  (Cooke 
Laboratory Products, Cooke Engineering Co., Arlington, Va.) in medium RPMI-1640 (GIB- 664  IMMUNE  RESPONSE  GENE  PRODUCT  FUNCTION 
CO) supplemented  with penicillin  (100 U/ml), streptomycin (100/~g/ml), L-glutamine  (300 
#g/ml), and 10% serum.  When alloantisera were added to the cell cultures equal parts of 
alloantisera and normal guinea pig serum were used. In those  experiments  where the anti- 
immunoglobulin reagents were added to the cultures, guinea pig serum was omitted and cell 
growth was supported by the addition of 10% fetal calf serum.  The final concentration of 
anti-immunoglobu~n  present in each culture represented  a  1:2 dilution of the original anti- 
serum. 
The cultures were maintained at 37°C for 72 h in a humid atmosphere of 5% CO2 in Mr. 
18  h  before  harvesting,  1.0 #Ci  of  tritiated thymidine  ([3H]thymidine,  6.7  Ci/mM, New 
England Nuclear Corp.)  was  added to each culture.  The amount of  [3H]thymidine-incor- 
porated into cellular DNA was measured with the aid of a semiautomated microharvesting 
device (10). Radioactivity was counted in a Beckman  liquid scintillation counter (Beckman 
Instruments, Fullerton, Calif.) and expressed as either total cpm/culture or as the difference 
between  control and  antigen stimulated cultures  (A cpm/culture).  In some  experiments 
because  of the variable capacity of different  sera to support growth in culture, the results 
were normalized and expressed as the fraction (Fx) of the PHA response: 
cpm with antigen -- cpm with no antigen 
Fx PHA Response = 
cpm with PHA -- cpm with no antigen. 
RESULTS 
The Relationship  of the Ability of Alloantisera to Inhibit  T-Lymphocyte  Pro- 
liferation and to Lyse B Lymphocytes.--In this and the companion paper (11), 
the anti-H activity of a serum is defined by its capacity to lyse lymphoid cells of 
appropriate phenotype in the presence of C. The capacity of a  serum to block 
Ir gene product function is measured by inhibition of the stimulation of DNA 
synthesis by  immune  FI lymphocytes by antigens,  the  response  to  which  is 
controlled by that Ir gene. Initially, we wished to compare the relative effect of 
dilution of the alloantiserum on  these two assays. The population of lympho- 
cytes used as targets in the cytotoxicity assay were L2C leukemia cells. These 
leukemia cells are of strain 2 origin and bear large amounts of strain 2 H  anti- 
gens. Furthermore, L2C cells are of B-cell derivation as evidenced by the pres- 
ence of surface immunoglobulin and the receptor for the third component of C 
(6).  The  top half of Fig.  1  illustrates the cytotoxic activity of the  13  anti-2 
serum for L2C leukemia cells at a number of different antibody dilutions. Even 
at a  dilution of 1 : 120,  15 %  5tCr release is observed from L2C cells. The lower 
half of Fig. 1 illustrates the inhibitory activity of this same anti-2 serum on the 
proliferation of F1 lymphocytes to DNP-GL  and  to PPD.  Complete suppres- 
sion of the DNP-GL  response is observed at a  1:10 and  1:20 antiserum dilu- 
tion. As reported previously (3), only minimal suppression of the response to 
PPD  is observed under these conditions. At a  1:120 dilution of the antiserum 
inhibition of the DNP-GL  response is no longer seen. We conclude from  this 
experiment that  the ability of the  13  anti-2  serum  to inhibit the response  to 
DNP-GL  in F~ animals is roughly related to its cytotoxic activity for the B- 
lymphocyte leukemia, L2C,  although  the inhibitory activity of the antiserum 
for T-lymphocyte proliferation tends to be lost at lower dilutions of antiserum 
than is the cytotoxic activity for L2C leukemia cells. ETHAN  M.  SHEVACH,  WILLIAM  E.  PAUL,  AND  IRA  GREEN  665 
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leukemia cells. Bottom, inhibition of the proliferative response of (2 X  13)F1 lymphocytes to 
DNP-GL and PPD. Results are expressed  as the fraction of the PHA response. 
Absorption  of  the  Alloantisera  with  "Immune"  or  "Nonimmune  Cells."-- 
Our initial studies on the inhibition of T-cell  function with alloantisera were 
performed  with  alloantisera  which  had  been  prepared  by  cross-immunizing 
strain 2 and strain 13 animals with lymph node and spleen cells; in these studies 
the lymph node cells used were obtained from animals immunized with CFA. 
Although the resultant antisera were effective inhibitors of T-cell function, one 
possible explanation for their activity is that they are directed not toward H 
antigen but rather toward unique antigenic determinants (idiotypes) of receptors 
with  specificity for DNP-GL.  If the inhibitory activity of the alloantisera is 
based  on  such  "anti-idiotype"  activity,  then  one  would  anticipate  that  the 
cells of an animal immune to DNP-GL would be much more effective than the 
cells of an animal immunized to another antigen  in absorbing the inhibitory 
activity. To evaluate this possibility a 13 anti-2 serum prepared against lymph 
node and spleen  cells from a  CFA immune animal was absorbed with either 
0.8 X  10  9 or 2.0 >(  10  9 lymph node and spleen cells from a strain 2 animal that 
had  received CFA  alone or with  similar numbers  of lymph node  and  spleen 
cells from an animal that had  received DNP-GL and  CFA.  The top half of 
Fig.  2  illustrates  the  residual  cytotoxic activity of  these  absorbed  sera  for 
strain 2 lymph node cells. No significant difference is noted in the ability of the 
DNP-GL or CFA cells to remove the cytotoxic activity of the anti-2 serum. In 
similar fashion (Fig. 2, bottom) no significant difference is noted in the ability 
of these two cell populations to remove the inhibitory activity from the anti-2 
serum; indeed, in the experiment illustrated the CFA cells were  slightly more 666  IMMUNE  RESPONSE  GENE  PRODUCT  FUNCTION 
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activity on the proliferation of  (2  X  13)F1 lymphocytes to  DNP-GL  or  GT.  Results are 
expressed as fraction of the PHA response. 
effective than the DNP-GL cells.  It therefore is unlikely that the anti-2 serum 
is  directed  against  unique  antigenic  determinants  of a  receptor specific for 
DNP-GL, which is represented in a clonal fashion on the population of DNP- 
GL immune cells. 
Absorption of the Anti-2 Serum with Different Populations of Lymphoid Cells.- 
We next determined the cellular distribution of the antigens against which the 
inhibitory antibodies of the anti-2 sera are directed. Our approach was  to ab- 
sorb  the anti-2  serum  with lymphoid  cells from a variety  of sources and to 
measure  the  diminution  in  cytotoxic titer and  in inhibitory activity.  Initial 
attempts  to absorb  inhibitory activity with  several nonlymphoid tissues  re- 
vealed that the relevant antigen is either absent from  these tissues or present 
at too low a density for us to detect by  these procedures.  Among  lymphoid 
cell populations we found a general correlation in the efficiency of absorption 
of cytotoxic activity and of inhibitory activity (Fig. 3). As we have previously 
reported  (7),  absorption  with  thymocytes  removed  little  of  the  cytotoxic 
activity of the anti-2  serum while absorption with  an equivalent number of 
L~C  cells  completely  removes  cytotoxic activity  (Fig.  3,  top).  Peritoneal 
exudate lymphocytes (PELs)  which  are mainly  T  lymphocytes are  also  in- 
effective in absorption of cytotoxic activity; lymph node lymphocytes, a mixed 
population of T and B lymphocytes, and unpurified PECs, a mixture of macro- 
phages, polymorphonuclear cells  and lymphocytes, partially remove cytotoxic ETHAN  ~.  SIIEVACH,  WILLIAM]  E. PAUl,  AND  IRA GREEN  667 
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FIo. 3.  Absorption of the  13  anti-2  serum with different populations  of lymphoid cells. 
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activity on the proliferation of (2 X  13)F1 lymphocytes to DNP-GL and PPD. Results are 
expressed as fraction of the PHA response. 
activity. The unabsorbed  anti-2  serum  (Fig. 3,  bottom)  completely inhibits 
the response of F1 PELs to DNP-GL and also causes moderate inhibition of 
the PPD response. The inhibitory activity of the anti-2 serum is only slightly 
diminished by absorption with thymocytes or PELs; absorption with lymph 
node cells  or exudate cells produces a  somewhat greater decrease in the  in- 
hibitory activity of the anti-2 serum. On the other hand, absorption with L2C 
cells produces the greatest decrease in the inhibitory capcacity of the antiserum. 
Nevertheless,  significant inhibitory activity is still present in  the antiserum 
even though there is no detectable cytotoxic activity. The results indicate that 
the tissue distribution of the antigens against which the cytotoxic activity and 
the inhibitory activity of the anti-2 sera are directed is generally similar. 
Further  Studies  on  Absorption  of  the  Anti-2  Serum  with  L2C  Cells.--The 
results of the above study demonstrated that neither immature T cells (thymo- 
cytes) nor mature T  cells  (exudate lymphocytes), in the numbers used, were 
capable of selectively removing the inhibitory activity of the anti-2 serum on 
F1 T-cell proliferation. On the other hand, absorption of the anti-2 serum with 
a  pure  population of B  cells,  L2C  leukemia cells,  resulted in  an  antiserum 
which was totally devoid of cytotoxic activity toward either lymph node cells 
or L2C cells yet retained some ability to inhibit the proliferation of F1 T  cells. 
In view of our initial demonstration that the cytotoxic fiters of the sera were 
somewhat higher than their inhibitory titers,  this observation suggests that 
following absorption of the anti-2  sermn with L~C cells  a  population of in- 
hibitory antibodies is obtained which lack anti-H activity, as demonstrated by 668  IMMUNE  RESPONSE  GENE  PRODUCT  :FUNCTION 
their lack of cytotoxicity. In order to evaluate this possibility, several lots of 
anti-2 serum were absorbed with L2C cells and their residual cytotoxic activity 
for L2C  cells  and  their  residual  T-cell  inhibitory  activity  measured.  Three 
representative experiments are illustrated in Table I. In Exp. 1 and 2 all of the 
cytotoxic activity of the anti-2 serum was removed and the absorbed antisera 
retained considerable, but not complete, inhibitory activity for T-cell prolifera- 
tion. In Exp. 2, a  control is included in which the unabsorbed anti-2 serum is 
TABLE I 
Absorption  of the 13-Anti-2 Serum with L2C Leukemia Cells: Effect  on Inhibition of In  Vitro 
Proliferative Response of (2 X  13)FI Lymphocytes to DNP-GL 
Scruln 
Exp. No.  13 Anti-2  13 Anti-2 absorbed 
Antigen  NGPS*  13 Anti-2 (1/20)  (1/160)  with L~C (1/20) 
0  709~  427  384 
DNP-GL  9,522  451  2,411 
PPD  15,781  10,178  16,594 
% 51Cr§ release  0%  62%  2% 
0  282  537  295  1,207 
DNP-GL  21,394  854  16,713  2,022 
PPD  7,353  9,064  11,555  7,210 
% 51Cr re~ase  0%  560-/o  0%  0% 
0  643  259  416 
DNP-GL  31,948  335  31,000 
PPD  55,890  65,107  75,805 
%51Cr release  0%  78%  0% 
* NGPS, normal guinea pigs serum. 
:~ Results are expressed as cpm/tube; each value is the mean of three determinations. 
§ %  61Cr release in the presence of C from labeled L2C cells by a given antiserum dilution. 
diluted to the point (1 : 160) where it just lacks cytotoxic activity for L2C cells. 
This serum had very little inhibitory activity, in contrast to the absorbed anti-2 
serum which  retained  substantial  inhibitory activity. However, the absorbed 
antiserum in Exp. 3 was totally devoid of both cytotoxic and T-cell inhibitory 
activity. These contrasting results were observed in a number of other experi- 
ments performed with  different  lots of the  anti-2  serum prepared in  similar 
fashion. Inhibition of the DNP-GL response by some lots of the absorbed anti- 
sera was almost complete, while other lots produced only marginal inhibition 
of the DNP-GL response. 
In two experiments involving sera which retained inhibitory activity after a 
single absorption with  109  L~C  cells,  the  absorption procedure  was  repeated ETHAN  M.  SHEVACH,  WILLIAM  E.  PAUL~  AND  IRA  GREEN  669 
(Fig. 4). Before the initial absorption both lots of the anti-2 serum (no. 220  and 
no.  495)  demonstrated significant  cytotoxic activity for strain  2  lymph node 
cells and produced  complete inhibition of the proliferative response to DNP- 
GL by F1 PELs. Following one absorption with L2C cells the cytotoxic activity 
was reduced to ~-~5 % and considerable, although not complete, inhibition of the 
DNP-GL response was still observed. After a second absorption with L2C cells, 
both lots of antisera were completely devoid of cytotoxic activity and the degree 
of inhibition  of the DNP-GL response was considerably diminished.  Indeed, 
although the absolute number of counts observed after stimulation with DNP- 
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Fla. 4.  Serial absorption of the 13 anti-2 serum with L2C leukemia cells. Two lots of anti-2 
serum (no. 220 and no. 495) were absorbed twice with 1 X  109 L2C leukemia cells. Top, 
residual cytotoxic activity  for  51Cr-labeled lymph  node cells. Bottom, residual inhibitory 
activity on the proliferation of (2 X  13)F1 lymphocytes to DNP-GL, PPD or PHA. Results 
are expressed as A cpm X 10  "-a. 
GL in  the presence of the  absorbed antisera  (21,000  cpm with  no.  220  and 
20,000 cpm with no. 492) was still less than the number of counts seen in the 
presence of normal serum (30,000 cpm) it is unlikely that this apparent inhibi- 
tion of the DNP-GL response was specific because an equal suppression of the 
PHA response was seen.  It is therefore likely that the observed suppression of 
the DNP-GL response is secondary to the  reduced  capacity of these serially 
absorbed antisera to support the growth of cells in culture. We conclude from 
these  studies  that  large numbers  of L2C  leukemia cells are  capable of com- 
pletely removing the inhibitory activity of the anti-2 sera on T-cell activation. 
The fact that cytotoxic activity can often be removed by smaller number of 
L2C cells than are required  to completely absorb inhibitory activity could be 
explained in two general ways: (a) The antigens against which the respective 
antibodies are directed,  although having generally similar  tissue  distribution 
are different and are present in somewhat different densities on these cells.  (b) 670  IMMUNE  RESPONSE GENE  PRODUCT  FUNCTION 
The antibodies mediating cytotoxicit), and blocking are directed at the same 
antigenic determinants, but it is easier to absorb the cytotoxic antibodies per- 
haps because of thmr molecular class or affinities. 
The Effect o/Anti-Immunoglobulin  Sera on the In Vitro Proliferative Response 
To  Antigen.--We  have  previously demonstrated  (3)  that  absorption  of  the 
alloantisera with gammaglobulin of the opposite strain failed to reduce their 
inhibitory effect on in vitro T-cell proliferation. We concluded from this study 
that it was unlikely that the inhibition of T-cell function produced by the allo- 
antisera  was  secondary to  contaminating  anti-immunoglobulin-allotype anti- 
bodies; however, the results of this study do not allow a conclusion to be drawn 
about the possible role of immuno!gobulin as the specific T-cell receptor. In- 
deed, we suggested that one possible role for the Ir gene product would be to 
function as an auxilliary receptor to the prime antigen-binding  receptor.  Ac- 
cording to this interpretation the alloantisera would inhibit T-cell function by 
interfering either directly or indirectly with this auxilliary receptor. In such a 
model, immunoglobulin would be the most likely candidate for the  "prime" 
antigen-binding receptor of T  cells. Thus, it is of interest to examine the effect 
of anti-immunoglobulin sera on the in vitro proliferative response to antigen 
under the identical experimental conditions where the inhibitory function of the 
alloantisera can be demonstrated.  F1 PELs were cultured in the presence of 
macrophages which had been pulsed with DNP-GL, GT, PPD, or PHA. Under 
these conditions the absolute concentration of antigen in the culture is limiting. 
This should increase the likelihood that inhibition would occur. A number of 
different anti-immunoglobulin sera were used:  (a)  a  polyvalent anti-GP  im- 
munoglobulin preparation which reacted with 3`1, 3'2,  3'M heavy chains and 
with Fab pieces; (b) an anti-3`2 reagent which was specific for 3`2 heavy chains; 
(c) two anti-Fab reagents which were specific for Fab determinants. All of the 
anti-immunoglobulin sera were devoid of any inhibitory effect (Fig. 5) and, in 
addition, failed to stimulate DNA synthesis in the absence of antigen. Although 
slight  deviations were  observed between  the  total  number  of  counts  incor- 
porated in the presence of normal rabbit serum and the number of counts in- 
corporated in the presence of the various anti-immunoglobulin sera, the degree 
of depression of the antigen response was no greater than the depression of the 
response to PHA. For example, anti-Fab 1 suppressed the response to all three 
antigens by about 20 %, but also suppressed the PHA  response to the same 
degree. Thus, the observed inhibition is probably secondary to variability in 
the ability of the different sera to support cell growth in vitro. Under the same 
conditions  the  anti-2  serum  produced  specific suppression  of  the  DNP-GL 
response (Fig. 5 A) and did not affect the GT, PPD,  or PHA responses. 
DISCUSSION 
We have previously demonstrated that alloantisera can specifically block the 
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FIG. 5. The effect of anti-immunoglobulin sera on the in vitro proliferative response to 
antigen. (2 X  13)F1 lymphocytes were cultured with DNP-GL,  GT, PPD,  or PHA-pulsed 
macrophages in the presence of normal serum, anti-2 serum, or anti-immunoglohulin sera. 
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linked  to  the  presence  of H  specificities  against  which  the  alloantisera  are 
directed  (3).  On  the basis of this, we concluded  that Ir genes produce a  cell 
surface-associated product and that this product plays a role in antigen recog- 
nition by the T lymphocyte. Although the manner by which alloantisera inhibit 
the process of antigenic recognition is not as yet known, one possible explana- 
tion is that alloantisera contain antibodies which are directly reactive with the 
products  of the  Ir genes.  In  the present  report we have further defined  the 
mechanisms  by  which  alloantisera  inhibit  antigen-induced  lymphocyte pro- 
liferation in vitro by examining the effect of absorption of the 13 anti-2 serum 
with different populations of lymphoid cells. 
In  the  initial  experiments reported  in  this paper we  tested  the possibility 
that the inhibitory activity of the alloantisera was due to the presence of anti- 
bodies specific for the unique antigenic determinants, or idiotypes, of clonally 
distributed  T-lymphocyte receptors. If this  were the case then  cells obtained 
from animals immunized to DNP-GL would be anticipated  to be much more 
efficient than cells from animals immunized to a  noncross-reactive antigen in 
absorbing  the  antibodies  which  inhibit  in  vitro  responsiveness  to  DNP-GL. 
This expectation is based on the assumption that the clone of T cells specific for 672  IMMUNE  RESPONSE  GENE  PRODUCT  FUNCTION 
DNP-GL would expand as a result of immunization. In fact, the cell popula- 
tions were equivalent in their absorptive capacity. Furthermore, in experiments 
not  reported here,  it  was  found  that  alloantisera  produced  by immunizing 
strain 13 guinea pigs with lymphocyetes from strain 2 guinea pigs immunized 
to DNP-GL were no more inhibitory of the  in  vitro  response  to  DNP-GL 
than  alloantisera  raised  against  lymphocytes from strain  2  guinea pigs  not 
immunized to DNP-GL. It is therefore highly unlikely that the inhibition of the 
response to DNP-GL of F1 lymphocytes is mediated by a population of anti- 
bodies directed at the idiotypic determinants of clonally distributed T-lympho- 
cyte receptors specific for DNP-GL. 
As outlined in  the introduction, the inhibitory activity of the  alloantisera 
could derive from antibodies directed at the Ir gene product itself or from anti- 
bodies directed at linked surface structures, such as "conventional" H antigens. 
A decision on this crucial point is, in fact, quite difficult as no method of identi- 
fying Ir gene products other than function now exists. Two types of approaches 
have been employed by us in  an effort to resolve this issue.  In the first, we 
sought to determine the tissue distribution of the antigen(s) against which the 
inhibitory antibodies are directed and to compare it with the tissue distribution 
of the antigen(s)  against  which the cytotoxic activity of the alloantisera are 
directed. In the second, we studied the inhibitory activity of the alloantisera 
against  cells from animals possessing  a  given Ir gene but lacking the histo- 
compatibility genes to which that Ir gene is normally linked. The results of the 
latter studies are presented in a companion paper (11). 
In the analysis of tissue distribution we assumed that the cytotoxic activity of 
the  alloantisera principally reflects antibodies specific for the  "serologically- 
defined" antigens of the guinea pig H complex. As discussed below, this assump- 
tion clearly oversimplifies the complex situation  now  known  to obtain from 
studies of the H-2 complex of mice. We have previously shown that stlain  2 
antigens definable by cytotoxicity with anti-2 sera are present in much larger 
amounts on B lymphocytes than on T  lymphocytes (7). The strain 2 antigen is 
clearly present on the T-cell surface as it can be detected by indirect immuno- 
fluorescence  ~ and, under some circumstances, by direct cytotoxicity3, 3 Studies 
to be presented separately have shown that these antigens are also easily detect- 
able on peritoneal macrophages but that they are either absent from or present 
in very low density on normal and malignant fibroblasts, and a hepatoma3 In 
the studies presented here we have extended our previous analysis of the lym- 
phoid distribution of the antigens against which the cytotoxic activity of 13 
anti-2 sera is directed. Furthermore, we have shown that the tissue distribution 
of the antigens against which the inhibitory activity of the 13 anti-2 sera are 
directed  is  quite  similar.  Thus,  populations  of  immature  T  lymphocytes 
2 Shevach, E. M., Z. Ben-Sasson, F. Finkelman, and I. Green. Manuscript in preparation. 
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(thymocytes) or of mature T  lymphocytes (column-purified peritoneal exudate 
lymphocytes) are  relatively ineffective in  absorbing  either  the  cytotoxic or 
inhibitory activity of these sera. Lymph node lymphocytes, a mixed B-cell-T- 
cell population, and unfractionated PEC are intermediate in their absorbtive 
activity,  and  L~C  leukemic  cells,  a  malignant  B-cell  population,  are  most 
efficient for absorbing both activities. Thus,  the  antigens  against  which  the 
cytotoxic and inhibitory activities are directed appear  to  be expressed to  a 
greater extent on B lymphocytes than on T lymphocytes and a general correla- 
tion  exists  in  the  capacity of the  various  tissues  employed to  absorb  both 
activities. 
More detailed analysis of absorbtion of inhibitory and cytotoxic activity of 
13 anti-2 sera by L~C cells reveals that cytotoxic activity can generally be ab- 
sorbed  by smaller numbers  of cells  than  are  required  to  absorb  inhibitory 
activity, although inhibitory activity can be completely removed when larger 
numbers of L~C cells are used. Since the cytotoxic activity of the sera used are 
detectable at lower serum concentrations than is the inhibitory activity, the 
preferencial removal of cytotoxic activity by absorption with L2C cells could 
be interpreted as evidence that the antigens against which the cytotoxic and 
inhibitory antibodies are directed are distinct. An equally plausible interpreta- 
tion of the results is  that  the  specificity of the  two types of antibodies  are 
similar, but that the cytotoxic antibodies are preferentially absorbed because 
they are of higher affinity or different molecular class than some or all of the 
inhibitory antibodies. 
Thus,  these results do not allow us  to definitively determine whether the 
inhibitory activity of the alloantisera is due to antibodies specific for Ir gene 
products or antibodies specific for linked antigens in the MHC. What is strik- 
ingly revealed is that the relevant antigen is present in much larger amounts on 
B lymphocytes than on T  lymphocytes. Thus, if the inhibitory alloantibodies 
are directed at Ir gene products, such products must exist on B cells in higher 
concentrations than on T cells. Although the bulk of evidence indicates that Ir 
genes express their principal function in T  lymphocytes, recent studies of cell 
cooperation between macrophages and T  lymphocytes (12,  13), and between T 
lymphocytes and B lymphocytes (14), raise the possibility that Ir gene products, 
or products of closely linked MHC genes, play a major role in such interactions. 
Thus,  expression of Ir  gene products on  the  surface of B  lymphocytes and 
macrophages, as well as on T  lymphocytes, is a distinct possibility.  It should 
be noted that the alloantisera can block T-cell activation by antigen, by inter- 
fering with H-determined macrophage-T-cell interaction, as well as by inter- 
fering with antigen interaction with Ir gene products on T  lymphocytes (12, 
13). Indeed, it is possible that the very same antibodies are responsible for both 
effects. 
In the above discussion we have regarded the cytotoxic alloantisera as detect- 
ing H  antigens and have implicitly assumed that putative antisera to Ir gene 674  IMMUNE  RESPONSE  GENE  PRODUCT  FUNCTION 
products would not be cytotoxic. These assumptions were based upon views of 
the specificity of alloantisera directed against MHC antigens of  mice and of 
men generally held when the present studies were begun (15).  At that time it 
was believed that cytotoxic sera which detected H-2 specificities were directed 
at the products of two genes, the K  gene, located at the "left" end of the H-2 
complex, and the D  gene, located at the "right" end of the H-2 complex. The 
Ir genes of the mouse had been shown to be distinct from, although linked to, 
the K  and D  genes and thus it was believed that cytotoxic antibodies directed 
at Ir gene products would be very difficult to produce. 
It  is  now  recognized that  this  schema  was  highly  over simplified.  Thus, 
antisera identifying MHC antigens which are not the product of K  or D  genes 
have  been  recently reported by at  least  five laboratories  (16-19).  4 In  some 
instances the genes controlling these antigens have been mapped into the region 
in which most Ir genes are located, although no evidence that such antigens are 
Ir gene products has yet been obtained. Interestingly, these antigens,  unlike 
the traditional H-2 antigens, are not present on some non-lymphoid tissues and, 
in at least two cases  (18),  3 these antigens have a  higher representation on B 
lymphocytes than on T  lymphocytes. 
In light of these new findings it is important to reevaluate the situation re- 
garding the guinea pig MHC, and in particular the relation of the Ir genes to 
the genes governing the antigens detected by cytotoxicity with 13 anti-2 and 
2 anti-13 sera. Strain 2 and strain 13 guinea pigs are highly inbred and promptly 
reject reciprocal skin grafts suggesting they differ at the major H  region of the 
species  (20L Moreover mixed lymhpocyte responses are observed when their 
cells are cultured together (21) 5 and these animals differ at Ir loci, supporting 
the concept that they differ in the MHC. Finally, backcross analysis reveals a 
linkage between Ir genes, possession of antigens against which cytotoxic allo- 
antisera  are  directed,  and  the  ability  to  reject  a  transplantable  guinea pig 
leukemia  (22). Thus, it appears certain that  the antigens detected by the  2 
anti-13 sera and the 13 anti-2 sera are coded for by MHC genes. Whether these 
genes are equivalent to the D  and K  genes of mice and to the LA and Four 
genes of humans, or alternatively to the more recently described mouse MHC 
genes is uncertain. The observation that the antigens detected by anti-2 allo- 
antisera are in higher amount on B  cells than on T  cells and are difficult to 
detect on many nonlymphoid cells strongly suggests that  these antigens  are 
more analogous  to  the products of the newer non-D, non-K  MHC  genes  of 
mice. Moreover, Sato and de Weck have described  a  series of histocompati- 
bility antigens of guinea pigs (A, B, C, and D) and have reported that strain  2 
and 13 guinea pigs both share  the B antigen (23). Thus, if (2-13) differences 
are  MHC  differences coded for by genes analogous to non-D, non-K genes of 
4 Hammerling, G., and H. O. McDevitt. Unpublished observations. 
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mice, the ABCD system of Sato  and de Weck may represent the guinea pig 
analogue of D and/or K. Studies are now in progress to evaluate these possi- 
bilities. 
It has been suggested that the products of the Ir genes might be the prime 
antigen-binding receptors of the T lymphocyte.  However, it is also possible that 
the Ir gene product might function as an auxilliary receptor for antigen and 
act in concert with the prime receptor.  According to this latter explanation, 
the Ir gene product need not be expressed in a clonal manner; in this event, the 
most likely candidate for the prime antigen-binding receptor of the T lympho- 
cyte would be immunoglobulin. We therefore examined the effect of a number 
of anti-immunoglobulin  reagents,  which had specificity for the heavy and/or 
light chains  of guinea  pig immunoglobulin,  on  the in vitro proliferative re- 
sponse both to antigens,  the response to which is known to be under genetic 
control,  and to antigens,  the response to which is not known to be under uni- 
genic control.  Under conditions in which we were able to completely and spe- 
cifically suppress the response of (2 X  13)FI T lymphocytes to DNP-GL with 
anti-2 serum, all of the anti-immunoglobulin  reagents were devoid of inhibitory 
effect on the response of these same F1 cells to DNP-GL, GT, or PPD. A num- 
ber of comments should be made about the interpretation of these experimental 
results. First, the population of lymphocytes used in these studies, the column- 
passaged peritoneal exudate lymphocytes, are composed of 95-100 % T lympho- 
cytes  (9). Stimulation of  T-cell  proliferation  by  the  anti-immunoglobulin 
reagents in the absence of antigen was not obselved, and thus it was not neces- 
sary to prepare Fab fragments of the anti-Ig sera. Second, in our studies antigen 
is presented to the T lymphocytes in the form of antigen-pulsed  macrophages. 
The macrophages  are  exposed  to antigen in  the presence  of normal serum, 
washed, and then added to the lymphocytes which have been preincubated in 
the anti-immunoglobulin  reagents.  Under these conditions  the anti-immuno- 
globulin reagents cannot inhibit the binding of antigen to cytophilic antibody 
present on immune macrophages as such binding occurs before the introduction 
of the antisera. These same anti-immunoglobulin  reagents, if present during the 
incubation of antigen and macrophages,  are very effective in the inhibition of 
binding of antigen to cytophilic antibody present on macrophages.  Third, it 
should be noted that the absolute  quantity of antigen added to the cultures 
when antigen pulsed macrophages are used is exceedingly small. It has recently 
been  shown that when low concentrations of antigen are used,  macrophage- 
cytophilic antibody is most important in antigen binding and thus in this situa- 
tion antigen binding to macrophages  is sensitive to blockade by anti-immuno- 
globulin reagents  (24). A previous  study (25) of the inhibition of antigen-in- 
duced proliferation of human lymphocytes by antilight-chain reagents demon- 
strated that the degree of inhibition was maximal when the absolute quantity of 
soluble antigen added to the cultures was limiting. Such reported instances of 
inhibition of T-lymphocyte activation by anti-immunoglobulin  reagents  may 676  IMMUNE  RESPONSE  GENE  PRODUCT  FUNCTION 
be  explained by the  effect of the  anti-immunoglobulin antibody on antigen 
binding by macrophages rather than on any direct effect on T lymphocytes. 
Our failure to inhibit T-cell proliferation with anti-immunoglobulin reagents 
cannot be interpreted as definitive evidence for the absence of immunoglobulin 
on the T-cell surface. It is possible that the antisera used failed to recognize 
determinants shared  between  serum  immunoglobulin and  a  putative  T-cell 
surface immunoglobulin. Alternatively, different classes  of T  cells which have 
different functional roles may have antigen receptors with different chemical 
characteristics. Thus, the T-cell subset responsible for helper activity in anti- 
body production may bear surface immunoglobulin, while the T  cells responsi- 
ble for DNA synthesis in vitro may recognize antigen through receptors of a 
different nature. In any case, the latter function is readily inhibitable by allo- 
antisera and not by anti-immunoglobulin. Our data strongly suggest that con- 
ventional serum-type immunoglobulin is not important in antigen recognition 
by the T  cells involved in the DNA synthetic response. 
SUMMARY 
It has been previously shown that alloantisera prepared by reciprocal im- 
munization of strain 2 and strain 13 guinea pigs specifically block the activation 
of T lymphocytes from immune guinea pigs by antigens, the response to which 
is controlled by Ir genes. In this report we have examined the effect of absorp- 
tion of the 13 anti-2 serum with different populations of lymphoid ceils. It is 
unlikely that the inhibitory activity of the anti-2 serum on the proliferation of 
(2  X  13)F1 lymphocytes to a  DNP derivative of a  copolymer of  L-glutamic 
and L-lysine (DNP-GL)  is due to the presence of antibodies  specific  for  the 
unique antigenic determinants (idiotypes) of clonally distributed T-lymphocyte 
receptors. Thus, cells obtained from a normal animal and a DNP-GL immune 
animal were equivalent in their absorptive capacity. Populations of T lympho- 
cytes were ineffective in absorbing either the cytotoxic or inhibitory activity 
of the anti-2 serum, while L~C leukemia cells, a malignant B-cell population, 
were most efficient in absorbing both activities. Thus,  the  antigen(s)  against 
which  the  cytotoxic and  inhibitory activities  are  directed  are  present  to  a 
greater  extent  on  B  lymphocytes than  on  T  lymphocytes. However,  these 
results do not allow us to definitively determine whether the inhibitory activity 
of the alloantisera is due to antibodies specific  for Ir gene products or  anti- 
bodies specific for linked antigens in the MHC. 
We also examined the effect of a  number of anti-immunoglobulin reagents 
which had specificity for the heavy and/or light chains of guinea pig immuno- 
globulin on the in vitro lymphocyte proliferative response to antigen. Under 
conditions in which we were able to completely and specifically suppress the 
response of (2  X  13)Ft lymphocytes to DNP-GL with anti-2 serum, the anti- 
immunoglobulin reagents were devoid of inhibitory effect on the response of 
these  same  F1  cells  to  DNP-GL,  a  copolymer of L-glutamic and L-tyrosine ETHAN  M.  SHEVACH,  WILLIAM  E.  PAUL~  AND  IRA  GREEN  677 
(GT), or purified protein derivative of tuberculin (PPD). These results strongly 
suggest  that  conventional  serum-type  immunoglobulin  is  not  important  in 
antigen recognition by the T cells involved in the DNA synthetic response. 
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